SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO
SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( www.sintx.com ) (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and related technologies, announced that it has been granted its sixth United States patent in the last year.
- SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( www.sintx.com ) (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and related technologies, announced that it has been granted its sixth United States patent in the last year.
- The surface antipathogenic properties of silicon nitride have been published extensively in the peer literature by SINTX as well as by outside investigators.
- (These coating and composite technologies are the foundation for recent and ongoing NIH-funded commercialization work at SINTX.)
- SINTX has forty-three patent applications that are currently pending around the world including in the United States, Asia, Europe, and Brazil.